)
Ahmedabad's Motera Stadium, with a seating capacity of 110,000, outdoes the Melbourne Cricket Ground (MCG), which can seat 100,024 people and was before this the biggest
Doctors are now shifting treatment protocol for Covid-19 at hospitals and invasive ventilation is not being preferred
The company has been directed to pay ex-gratia to the next of kin of the deceased workers
The fire had erupted after a blast in the factory in the early hours of Tuesday. Twenty injured an five labourers missing as well
Fewer companies plan to give zero increment
The highest compensation package for the Global MBA class stood at Rs 43.9 lakh while that for the MGB program was Rs 35 lakh
Severely affected by the pandemic, the businesses have made a spectacular comeback
In a Q&A, Banerjee says the company is unlikely to change its model of leasing to Indian Railways, but is open to financing private projects that have forward or backward linkages with railways
Bourse will run on a delivery-based model for allocated and unallocated bullion, with underlying security backing the latter
Firm to expand product basket, prepares for entry into European market
Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients
The firm's consolidated total revenue dipped 53% to Rs 45 cr
Offering two-year full-time MBA, the 'new-age global' B-school in Mumbau aims at covering emerging technology, design thinking and analytics
Company plans to launch four variants of high performance e-bikes at the plant, which is estimated to generate direct and indirect employment for 6,000 persons
Designed to cater to the mass adoption market, the vehicles will be eligible for FAME-II subsidies
From its previous close of Rs 441.95 apiece on Thursday, the stock closed 10.89 per cent or Rs 48.15 lower at Rs 393.80, on Friday
Nearly 1,500 acres park to attract investments worth Rs 50,000 crore in logistics, transport
Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"
Biocon's consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year
Consolidated revenue rises by 11.59 per cent to Rs 601.6 crore